Completed Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine NCT01592747 Conditions Asperger Syndrome, Asperger's Disorder, Autism, +7 more Locations Forest Investigative Site 068 — Dothan, Alabama, United States Forest Investigative Site 005 — Phoenix, Arizona, United States Forest Investigative Site 055 — Tucson, Arizona, United States Forest Investigative Site 077 — Little Rock, Arkansas, United States View all 94 locations View more locations Show fewer locations Loading locations... View Trial Details
